Smoking Cessation & Nicotine De-Addiction Product Market to Reach $4.56 Billion by 2027 - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Smoking Cessation & Nicotine De-Addiction Product Market Research Report by Product (Drug Therapy, E-Cigarettes, and Nicotine Inhalers), Distribution, State - United States Forecast to 2027 - Cumulative Impact of COVID-19" report has been added to ResearchAndMarkets.com's offering.

The United States Smoking Cessation & Nicotine De-Addiction Product Market size was estimated at USD 2,618.45 million in 2021 and expected to reach USD 2,882.28 million in 2022, and is projected to grow at a Compound Annual Growth Rate (CAGR) of 9.69% to reach USD 4,562.44 million by 2027.

Market Segmentation & Coverage:

This research report categorizes the Smoking Cessation & Nicotine De-Addiction Product to forecast the revenues and analyze the trends in each of the following sub-markets:

• Based on Product, the market was studied across Drug Therapy, E-Cigarettes, Nicotine Inhalers, Nicotine Replacement Therapies, and Nicotine Sublingual Tablets. The Drug Therapy is further studied across Chantix (Varenicline) and Zyban (Bupropion). The Nicotine Replacement Therapies is further studied across Nicotine Gums, Nicotine Lozenges, Nicotine Sprays, and Nicotine Transdermal Patches.
• Based on Distribution, the market was studied across Drug Store, Hospital Pharmacies, Online Pharmacies, and Retail Pharmacies.
• Based on State, the market was studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas.

   

Key Topics Covered:

1. Preface

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

5.1. Market Dynamics

5.1.1. Drivers

5.1.2. Restraints

5.1.3. Opportunities

5.1.4. Challenges

5.2. Cumulative Impact of COVID-19

6. Smoking Cessation & Nicotine De-Addiction Product Market, by Product

7. Smoking Cessation & Nicotine De-Addiction Product Market, by Distribution

8. California Smoking Cessation & Nicotine De-Addiction Product Market

9. Florida Smoking Cessation & Nicotine De-Addiction Product Market

10. Illinois Smoking Cessation & Nicotine De-Addiction Product Market

11. New York Smoking Cessation & Nicotine De-Addiction Product Market

12. Ohio Smoking Cessation & Nicotine De-Addiction Product Market

13. Pennsylvania Smoking Cessation & Nicotine De-Addiction Product Market

14. Texas Smoking Cessation & Nicotine De-Addiction Product Market

15. Competitive Landscape

Companies Mentioned

• 22nd Century Group, Inc.
• Axsome Therapeutics, Inc.
• British American Tobacco PLC
• Cipla Ltd.
• Dr. Reddy's Laboratories Ltd.
• GlaxoSmithKline PLC
• Imperial Tobacco Company of India Limited
• Japan Tobacco Inc.
• Johnson & Johnson
• JUUL Labs Inc.
• NJOY, Inc.
• Novartis International AG
• Perrigo Company PLC
• Pfizer, Inc.
• Philip Morris International Inc.
• Revolymer PLC by Itaconix
• Takeda Pharmaceutical Co., Ltd.

For more information about this report visit https://www.researchandmarkets.com/r/8juck8

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900